Shares

27 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q1 2024

Apr 25, 2024

BUY
$209.01 - $232.56 $10 Million - $11.1 Million
47,849 Added 37.25%
176,313 $38.5 Million
Q4 2023

Feb 06, 2024

SELL
$197.69 - $227.29 $8.43 Million - $9.69 Million
-42,645 Reduced 24.92%
128,464 $29.2 Million
Q3 2023

Nov 13, 2023

BUY
$201.05 - $221.7 $3.51 Million - $3.87 Million
17,436 Added 11.35%
171,109 $34.4 Million
Q2 2023

Aug 15, 2023

BUY
$211.93 - $241.33 $6.95 Million - $7.92 Million
32,807 Added 27.14%
153,673 $31.9 Million
Q1 2023

May 11, 2023

SELL
$213.32 - $257.83 $2.89 Million - $3.49 Million
-13,532 Reduced 10.07%
120,866 $27.7 Million
Q4 2022

Jan 27, 2023

BUY
$203.72 - $248.97 $5.73 Million - $7 Million
28,126 Added 26.47%
134,398 $31.6 Million
Q3 2022

Nov 14, 2022

BUY
$204.81 - $262.19 $7.73 Million - $9.9 Million
37,741 Added 55.07%
106,272 $21.8 Million
Q2 2022

Aug 12, 2022

SELL
$213.86 - $277.87 $966,433 - $1.26 Million
-4,519 Reduced 6.19%
68,531 $16.1 Million
Q1 2022

May 12, 2022

BUY
$259.82 - $298.18 $6.81 Million - $7.81 Million
26,198 Added 55.92%
73,050 $19.3 Million
Q4 2021

Feb 08, 2022

SELL
$271.6 - $314.21 $1.52 Million - $1.75 Million
-5,583 Reduced 10.65%
46,852 $14.7 Million
Q3 2021

Nov 15, 2021

SELL
$274.82 - $308.34 $2.19 Million - $2.46 Million
-7,978 Reduced 13.21%
52,435 $14.8 Million
Q2 2021

Aug 12, 2021

BUY
$251.87 - $278.14 $543,283 - $599,947
2,157 Added 3.7%
60,413 $16.7 Million
Q1 2021

May 05, 2021

SELL
$204.88 - $255.03 $98,752 - $122,924
-482 Reduced 0.82%
58,256 $14.9 Million
Q4 2020

Feb 12, 2021

BUY
$186.91 - $214.42 $182,797 - $209,702
978 Added 1.69%
58,738 $12 Million
Q3 2020

Nov 12, 2020

SELL
$167.03 - $201.3 $114,248 - $137,689
-684 Reduced 1.17%
57,760 $10.9 Million
Q2 2020

Aug 11, 2020

BUY
$113.31 - $182.44 $901,720 - $1.45 Million
7,958 Added 15.76%
58,444 $9.71 Million
Q1 2020

Apr 27, 2020

BUY
$104.32 - $195.28 $1.59 Million - $2.97 Million
15,212 Added 43.13%
50,486 $6.38 Million
Q4 2019

Feb 10, 2020

BUY
$163.48 - $173.61 $237,045 - $251,734
1,450 Added 4.29%
35,274 $5.97 Million
Q3 2019

Nov 12, 2019

BUY
$159.77 - $178.1 $366,672 - $408,739
2,295 Added 7.28%
33,824 $5.68 Million
Q2 2019

Aug 12, 2019

BUY
$144.16 - $172.9 $221,862 - $266,093
1,539 Added 5.13%
31,529 $5.45 Million
Q1 2019

May 15, 2019

BUY
$123.7 - $156.3 $727,727 - $919,512
5,883 Added 24.4%
29,990 $4.59 Million
Q4 2018

Feb 13, 2019

SELL
$120.82 - $174.09 $746,305 - $1.08 Million
-6,177 Reduced 20.4%
24,107 $3.05 Million
Q3 2018

Nov 13, 2018

BUY
$167.67 - $188.27 $335,843 - $377,104
2,003 Added 7.08%
30,284 $5.26 Million
Q2 2018

Aug 14, 2018

BUY
$160.33 - $189.41 $573,821 - $677,898
3,579 Added 14.49%
28,281 $0
Q1 2018

May 10, 2018

BUY
$161.53 - $178.11 $264,747 - $291,922
1,639 Added 7.11%
24,702 $4 Million
Q4 2017

Feb 14, 2018

BUY
$147.99 - $163.95 $232,936 - $258,057
1,574 Added 7.32%
23,063 $3.68 Million
Q3 2017

Nov 14, 2017

BUY
$149.47 - $160.56 $3.21 Million - $3.45 Million
21,489
21,489 $3.24 Million

Others Institutions Holding LH

About LABORATORY CORP OF AMERICA HOLDINGS


  • Ticker LH
  • Exchange NYSE
  • Sector Healthcare
  • Industry Diagnostics & Research
  • Shares Outstandng 89,600,000
  • Market Cap $21.7B
  • Description
  • Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...
More about LH
Track This Portfolio

Track Natixis Advisors, L.P. Portfolio

Follow Natixis Advisors, L.P. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Natixis Advisors, L.P., based on Form 13F filings with the SEC.

News

Stay updated on Natixis Advisors, L.P. with notifications on news.